https://timmermanreport.com/2025/10/food-intelligence-make-healthy-the-default-in-public-spaces-and-private-kitchens/screenshot-2025-10-06-at-11-37-59%e2%80%afam/2025-10-06T15:38:39+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-06-at-11.37.59%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/food-intelligence-make-healthy-the-default-in-public-spaces-and-private-kitchens/screenshot-2025-10-06-at-11-37-38%e2%80%afam/2025-10-06T15:39:29+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-06-at-11.37.38%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/food-intelligence-make-healthy-the-default-in-public-spaces-and-private-kitchens/screenshot-2025-10-06-at-11-40-10%e2%80%afam/2025-10-06T15:41:01+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-06-at-11.40.10%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/food-intelligence-make-healthy-the-default-in-public-spaces-and-private-kitchens/screenshot-2025-10-06-at-11-41-44%e2%80%afam/2025-10-06T15:42:21+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-06-at-11.41.44%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k1/2025-10-06T16:03:06+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k1-e1759768498224.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k2/2025-10-06T16:03:07+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k2.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k3/2025-10-06T16:03:08+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k3.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k4/2025-10-06T16:03:10+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k4.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k5/2025-10-06T16:03:11+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k5.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k6/2025-10-06T16:03:12+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k6.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k7/2025-10-06T16:03:14+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k7.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k8/2025-10-06T16:03:15+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k8-e1759768354942.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k9/2025-10-06T16:03:16+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k9.jpghttps://timmermanreport.com/2025/10/an-outstanding-mini-traverse-of-katahdin-for-damon-runyon-cancer-research/k10/2025-10-06T16:03:18+00:00https://timmermanreport.com/wp-content/uploads/2025/10/k10.jpghttps://timmermanreport.com/2025/10/silicon-valley-yes-ai-does-enhances-productivity-in-the-right-hands-context/img\_9731-1/2025-10-06T19:58:13+00:00https://timmermanreport.com/wp-content/uploads/2025/10/IMG\_9731-1.jpghttps://timmermanreport.com/2025/10/silicon-valley-yes-ai-does-enhances-productivity-in-the-right-hands-context/screenshot-2025-10-06-at-4-04-18%e2%80%afpm/2025-10-06T20:08:00+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-06-at-4.04.18%E2%80%AFPM.pnghttps://timmermanreport.com/2025/10/silicon-valley-yes-ai-does-enhances-productivity-in-the-right-hands-context/screenshot-2025-10-06-at-4-05-56%e2%80%afpm/2025-10-06T20:10:13+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-06-at-4.05.56%E2%80%AFPM.pnghttps://timmermanreport.com/2025/10/too-many-life-sciences-boards-are-shirking-their-responsibilities/johnarcher/2025-10-08T20:26:05+00:00https://timmermanreport.com/wp-content/uploads/2025/10/johnarcher.pnghttps://timmermanreport.com/the-long-run/dash\_logo\_lock\_up\_rgb\_black/2025-10-08T21:18:58+00:00https://timmermanreport.com/wp-content/uploads/2025/10/dash\_logo\_lock\_up\_rgb\_black.jpghttps://timmermanreport.com/2025/10/creating-a-new-class-of-medicines-eric-fischer-on-the-long-run/ericfischer/2025-10-14T16:15:36+00:00https://timmermanreport.com/wp-content/uploads/2025/10/ericfischer.pnghttps://timmermanreport.com/2025/10/novo-buys-akero-bms-bets-on-orbital-in-vivo-car-t-a-biotech-industry-nobel/ronphilip/2025-10-16T23:05:25+00:00https://timmermanreport.com/wp-content/uploads/2025/10/ronphilip.jpghttps://timmermanreport.com/2025/10/novo-buys-akero-bms-bets-on-orbital-in-vivo-car-t-a-biotech-industry-nobel/jillmilne/2025-10-16T23:06:15+00:00https://timmermanreport.com/wp-content/uploads/2025/10/jillmilne.jpghttps://timmermanreport.com/2015/07/pay-cut-thats-ok-wall-street-veterans-find-new-purpose-in-biotech-life/lorence-kim-v2-157x210/2025-10-16T23:07:29+00:00https://timmermanreport.com/wp-content/uploads/2015/07/lorence-kim-v2-157x210.jpghttps://timmermanreport.com/2025/10/novo-buys-akero-bms-bets-on-orbital-in-vivo-car-t-a-biotech-industry-nobel/pruzanski/2025-10-16T23:09:08+00:00https://timmermanreport.com/wp-content/uploads/2025/10/pruzanski.jpghttps://timmermanreport.com/2025/10/novo-buys-akero-bms-bets-on-orbital-in-vivo-car-t-a-biotech-industry-nobel/nelsenregs/2025-10-16T23:09:46+00:00https://timmermanreport.com/wp-content/uploads/2025/10/nelsenregs.pnghttps://timmermanreport.com/2025/10/novo-buys-akero-bms-bets-on-orbital-in-vivo-car-t-a-biotech-industry-nobel/screenshot-2025-10-16-161516/2025-10-16T23:15:49+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-16-161516.pnghttps://timmermanreport.com/2025/10/takeda-bets-on-innovent-newlimit-lures-lilly-merck-made-in-america/owens/2025-10-23T22:35:47+00:00https://timmermanreport.com/wp-content/uploads/2025/10/owens.pnghttps://timmermanreport.com/2023/04/crispr-vertex-seek-fda-milestone-canaan-pulls-in-850m-cutting-out-the-middleman/mathai/2025-10-23T22:37:10+00:00https://timmermanreport.com/wp-content/uploads/2023/04/mathai.jpghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-26-57%e2%80%afam/2025-10-24T15:28:37+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.26.57%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-30-12%e2%80%afam/2025-10-24T15:31:10+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.30.12%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-32-10%e2%80%afam/2025-10-24T15:33:09+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.32.10%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-34-59%e2%80%afam/2025-10-24T15:36:09+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.34.59%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-41-48%e2%80%afam/2025-10-24T15:44:34+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.41.48%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-45-44%e2%80%afam/2025-10-24T15:48:56+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.45.44%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-50-46%e2%80%afam/2025-10-24T15:51:59+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.50.46%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-52-27%e2%80%afam/2025-10-24T15:53:34+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.52.27%E2%80%AFAM.pnghttps://timmermanreport.com/2025/10/the-biology-of-belonging-social-connection-meets-geroscience/screenshot-2025-10-24-at-11-55-18%e2%80%afam/2025-10-24T15:56:50+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-24-at-11.55.18%E2%80%AFAM.pnghttps://timmermanreport.com/2016/05/immuno-oncology-whos-part-2/krieg/2025-10-28T12:58:42+00:00https://timmermanreport.com/wp-content/uploads/2016/05/krieg.jpghttps://timmermanreport.com/2024/11/developing-a-new-class-of-rna-therapeutics-leslie-williams-on-the-long-run/leslie-2/2025-10-28T18:51:48+00:00https://timmermanreport.com/wp-content/uploads/2024/11/leslie.pnghttps://timmermanreport.com/2025/10/the-outsized-significance-of-a-new-study-of-ai-in-diabetes-prevention/screenshot-2025-10-30-at-12-44-00%e2%80%afpm/2025-10-30T16:45:10+00:00https://timmermanreport.com/wp-content/uploads/2025/10/Screenshot-2025-10-30-at-12.44.00%E2%80%AFPM.pnghttps://timmermanreport.com/2025/09/corsera-health-led-by-maraganore-and-meanwell-aims-to-prevent-heart-disease/clive-meanwell-1600x1600/2025-10-30T23:18:30+00:00https://timmermanreport.com/wp-content/uploads/2025/08/Clive-Meanwell-1600x1600-1.jpghttps://timmermanreport.com/2025/10/novartis-acquires-avidity-for-12b-novo-stiff-arms-pfizer-intellia-woes/luispena/2025-10-30T23:21:51+00:00https://timmermanreport.com/wp-content/uploads/2025/10/luispena.pnghttps://timmermanreport.com/2025/10/novartis-acquires-avidity-for-12b-novo-stiff-arms-pfizer-intellia-woes/jonas/2025-10-30T23:24:30+00:00https://timmermanreport.com/wp-content/uploads/2025/10/jonas.pnghttps://timmermanreport.com/2025/11/manifold-bio-pockets-55m-from-roche-for-blood-brain-barrier-shuttles/manifold1/2025-11-01T00:13:47+00:00https://timmermanreport.com/wp-content/uploads/2025/11/manifold1.jpghttps://timmermanreport.com/2025/11/novo-pfizer-bidding-war-billiontoone-ipo-fda-turmoil/recursionleaders/2025-11-07T03:43:07+00:00https://timmermanreport.com/wp-content/uploads/2025/11/recursionleaders.pnghttps://timmermanreport.com/2020/12/14834/liebisch-2019/2025-11-07T03:44:05+00:00https://timmermanreport.com/wp-content/uploads/2020/12/liebisch-2019.jpghttps://timmermanreport.com/2025/11/novo-pfizer-bidding-war-billiontoone-ipo-fda-turmoil/travis/2025-11-07T03:46:58+00:00https://timmermanreport.com/wp-content/uploads/2025/11/travis.jpghttps://timmermanreport.com/2025/11/reinventing-drug-discovery-with-ai-marc-tessier-lavigne-on-the-long-run/mtl-2/2025-11-12T15:52:51+00:00https://timmermanreport.com/wp-content/uploads/2025/11/mtl.pnghttps://timmermanreport.com/2025/11/gate-bioscience-secures-65m-to-turn-off-disease-proteins-at-the-source/jordi-2/2025-11-12T21:21:03+00:00https://timmermanreport.com/wp-content/uploads/2025/11/jordi.pnghttps://timmermanreport.com/2025/11/pfizer-grabs-metsera-merck-delivers-oral-pcsk9-kura-wins-1st-fda-ok/megalexander/2025-11-14T00:48:22+00:00https://timmermanreport.com/wp-content/uploads/2025/11/megalexander.pnghttps://timmermanreport.com/2019/11/running-the-kras-marathon-with-wellspring-and-visualizing-a-second-half-kick/troy\_wilson\_34v03/2025-11-14T00:49:11+00:00https://timmermanreport.com/wp-content/uploads/2019/11/troy\_wilson\_34v03.jpghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/deanli/2025-11-14T00:50:52+00:00https://timmermanreport.com/wp-content/uploads/2021/05/deanli.pnghttps://timmermanreport.com/2025/11/seattles-ai-biotech-leaders-see-hype-hope-and-hard-problems/chrispicardo/2025-11-14T20:13:25+00:00https://timmermanreport.com/wp-content/uploads/2025/11/chrispicardo.pnghttps://timmermanreport.com/2025/11/the-dark-side-of-the-glp-1-weight-loss-drugs-eating-disorders/amandabanks/2025-11-18T00:15:48+00:00https://timmermanreport.com/wp-content/uploads/2025/11/amandabanks.pnghttps://timmermanreport.com/2025/11/the-dark-side-of-the-glp-1-weight-loss-drugs-eating-disorders/abanks/2025-11-18T00:18:10+00:00https://timmermanreport.com/wp-content/uploads/2025/11/abanks.jpghttps://timmermanreport.com/2025/11/merck-buys-cidara-abbott-acquires-exact-function-flies/distracted/2025-11-21T00:38:57+00:00https://timmermanreport.com/wp-content/uploads/2025/11/distracted.pnghttps://timmermanreport.com/2025/11/merck-buys-cidara-abbott-acquires-exact-function-flies/crews/2025-11-21T00:41:48+00:00https://timmermanreport.com/wp-content/uploads/2025/11/crews.pnghttps://timmermanreport.com/2025/11/merck-buys-cidara-abbott-acquires-exact-function-flies/francesco-de-rubertis/2025-11-21T00:43:17+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Francesco-De-Rubertis.jpghttps://timmermanreport.com/2025/06/sanofi-buys-blueprint-bms-antes-for-biontech-bispecific-kymera-degrader-delivers/katehaviland/2025-11-21T00:44:18+00:00https://timmermanreport.com/wp-content/uploads/2025/06/katehaviland.jpghttps://timmermanreport.com/2025/11/why-patients-and-many-innovative-doctors-are-pursuing-health-outside-the-system/screenshot-2025-11-22-at-1-06-08%e2%80%afpm/2025-11-22T18:07:43+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Screenshot-2025-11-22-at-1.06.08%E2%80%AFPM.pnghttps://timmermanreport.com/2025/11/why-patients-and-many-innovative-doctors-are-pursuing-health-outside-the-system/screenshot-2025-11-22-at-1-10-09%e2%80%afpm/2025-11-22T18:11:18+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Screenshot-2025-11-22-at-1.10.09%E2%80%AFPM.pnghttps://timmermanreport.com/2025/11/why-patients-and-many-innovative-doctors-are-pursuing-health-outside-the-system/screenshot-2025-11-22-at-1-11-49%e2%80%afpm/2025-11-22T18:12:32+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Screenshot-2025-11-22-at-1.11.49%E2%80%AFPM.pnghttps://timmermanreport.com/2025/11/why-patients-and-many-innovative-doctors-are-pursuing-health-outside-the-system/screenshot-2025-11-22-at-1-13-15%e2%80%afpm/2025-11-22T18:14:20+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Screenshot-2025-11-22-at-1.13.15%E2%80%AFPM.pnghttps://timmermanreport.com/2025/11/why-patients-and-many-innovative-doctors-are-pursuing-health-outside-the-system/hhaa\_conf2025\_415red/2025-11-22T18:30:08+00:00https://timmermanreport.com/wp-content/uploads/2025/11/HHAA\_Conf2025\_415red-scaled.jpghttps://timmermanreport.com/2025/11/why-patients-and-many-innovative-doctors-are-pursuing-health-outside-the-system/screenshot-2025-11-22-at-1-33-25%e2%80%afpm/2025-11-22T18:36:06+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Screenshot-2025-11-22-at-1.33.25%E2%80%AFPM.pnghttps://timmermanreport.com/2025/11/london-life-sciences-week-shows-uk-biotech-is-open-and-thriving/emma/2025-11-25T21:55:45+00:00https://timmermanreport.com/wp-content/uploads/2025/11/emma.pnghttps://timmermanreport.com/2025/11/london-life-sciences-week-shows-uk-biotech-is-open-and-thriving/jack/2025-11-25T21:56:47+00:00https://timmermanreport.com/wp-content/uploads/2025/11/jack.jpghttps://timmermanreport.com/2025/11/london-life-sciences-week-shows-uk-biotech-is-open-and-thriving/portrait\_of\_lord\_patrick\_vallance-\_54841243168/2025-11-25T22:02:38+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Portrait\_of\_Lord\_Patrick\_Vallance.\_54841243168.jpghttps://timmermanreport.com/2025/11/a-new-book-on-glp-1s-contested-scientific-roots-and-complex-cultural-impact-plus-further-reading/screenshot-2025-11-27-at-12-15-40%e2%80%afpm/2025-11-27T17:17:42+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Screenshot-2025-11-27-at-12.15.40%E2%80%AFPM.pnghttps://timmermanreport.com/2025/11/a-new-book-on-glp-1s-contested-scientific-roots-and-complex-cultural-impact-plus-further-reading/screenshot-2025-11-27-at-12-44-44%e2%80%afpm/2025-11-27T17:48:05+00:00https://timmermanreport.com/wp-content/uploads/2025/11/Screenshot-2025-11-27-at-12.44.44%E2%80%AFPM.pnghttps://timmermanreport.com/2025/12/fda-turmoil-continues/padzur\_richard-34/2025-12-05T02:44:44+00:00https://timmermanreport.com/wp-content/uploads/2025/12/padzur\_richard-34.jpghttps://timmermanreport.com/2025/12/fda-turmoil-continues/kent/2025-12-05T02:53:28+00:00https://timmermanreport.com/wp-content/uploads/2025/12/kent.pnghttps://timmermanreport.com/2025/12/psithera-gets-47-5m-for-small-molecules-against-tnf-superfamily-targets/eric-headshot/2025-12-10T02:45:54+00:00https://timmermanreport.com/wp-content/uploads/2025/12/Eric-Headshot.pnghttps://timmermanreport.com/2025/12/5am-orbimed-join-70m-bet-on-prolynx-long-lasting-glp-1-weight-loss-medicines/chris-boulton/2025-12-10T23:57:24+00:00https://timmermanreport.com/wp-content/uploads/2025/12/Chris-Boulton.jpghttps://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/reupdated/2025-12-11T20:20:34+00:00https://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/pflavin/2025-12-11T20:27:00+00:00https://timmermanreport.com/wp-content/uploads/2025/12/pflavin.jpghttps://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/flav1/2025-12-11T20:28:55+00:00https://timmermanreport.com/wp-content/uploads/2025/12/flav1.pnghttps://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/flav2/2025-12-11T20:29:25+00:00https://timmermanreport.com/wp-content/uploads/2025/12/flav2.pnghttps://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/gianneschi-4-29-24/2025-12-11T20:41:13+00:00https://timmermanreport.com/wp-content/uploads/2025/12/gianneschi.4.29.24.jpghttps://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/sarah-hein-headshot/2025-12-11T20:43:30+00:00https://timmermanreport.com/wp-content/uploads/2025/12/sarah-hein-headshot.pnghttps://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/tgajewski/2025-12-11T20:46:12+00:00https://timmermanreport.com/wp-content/uploads/2025/12/tgajewski.pnghttps://timmermanreport.com/2025/12/the-next-alzheimers-treatments-may-spur-the-brain-to-protect-itself/niels-head-shot-bw/2025-12-17T04:37:14+00:00https://timmermanreport.com/wp-content/uploads/2025/12/Niels-head-shot-bw.jpghttps://timmermanreport.com/2026/01/variant-bio-attracts-boehringer-with-ai-discovery-of-kidney-disease-targets/farnum-2/2026-01-06T03:33:42+00:00https://timmermanreport.com/wp-content/uploads/2026/01/farnum.jpghttps://timmermanreport.com/2026/01/variant-bio-attracts-boehringer-with-ai-discovery-of-kidney-disease-targets/castel/2026-01-06T03:35:06+00:00https://timmermanreport.com/wp-content/uploads/2026/01/castel.jpghttps://timmermanreport.com/2026/01/timmerman-traverse-for-damon-runyon-hits-1m-goal-still-striving-toward-kilimanjaro/alaporte/2026-01-06T22:12:00+00:00https://timmermanreport.com/wp-content/uploads/2026/01/alaporte.jpghttps://timmermanreport.com/2026/01/timmerman-traverse-for-damon-runyon-hits-1m-goal-still-striving-toward-kilimanjaro/logo-green\_ffff-1758292824-2/2026-01-06T22:14:09+00:00https://timmermanreport.com/wp-content/uploads/2026/01/logo-green\_ffff-1758292824.pnghttps://timmermanreport.com/2026/01/timmerman-traverse-for-damon-runyon-hits-1m-goal-still-striving-toward-kilimanjaro/recursionlogo/2026-01-06T22:14:46+00:00https://timmermanreport.com/wp-content/uploads/2026/01/recursionlogo.pnghttps://timmermanreport.com/2026/01/timmerman-traverse-for-damon-runyon-hits-1m-goal-still-striving-toward-kilimanjaro/ttdamonrunyon/2026-01-06T22:19:54+00:00https://timmermanreport.com/wp-content/uploads/2026/01/TTdamonRunyon.pnghttps://timmermanreport.com/2026/01/biotech-needs-its-own-david-sacks/pmalone/2026-01-07T02:45:01+00:00https://timmermanreport.com/wp-content/uploads/2026/01/pmalone.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/johncass/2026-01-13T04:16:40+00:00https://timmermanreport.com/wp-content/uploads/2026/01/johncass.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass1/2026-01-13T04:18:48+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass1.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass2/2026-01-13T04:22:27+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass2.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass3/2026-01-13T04:22:58+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass3.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass4/2026-01-13T04:23:21+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass4.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass5/2026-01-13T04:24:01+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass5.pnghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass6/2026-01-13T04:24:42+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass6.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass7/2026-01-13T04:25:10+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass7.jpghttps://timmermanreport.com/2026/01/sovereign-risk-the-geopolitical-price-of-outsourcing-the-biotech-engine/cass8/2026-01-13T04:25:42+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cass8.jpghttps://timmermanreport.com/2026/01/novo-wegovy-pill-lilly-acquires-ventyx-and-aktis-breaks-ipo-ice/mattroden/2026-01-16T01:04:07+00:00https://timmermanreport.com/wp-content/uploads/2026/01/mattroden.jpghttps://timmermanreport.com/2026/01/novo-wegovy-pill-lilly-acquires-ventyx-and-aktis-breaks-ipo-ice/robertclarke/2026-01-16T01:06:08+00:00https://timmermanreport.com/wp-content/uploads/2026/01/robertclarke.pnghttps://timmermanreport.com/the-long-run/as\_logotype\_positive/2026-01-21T21:24:15+00:00https://timmermanreport.com/wp-content/uploads/2026/01/AS\_Logotype\_Positive.pnghttps://timmermanreport.com/2026/01/helping-people-lose-weight-and-live-healthy-ron-renaud-on-the-long-run/renaud-2/2026-01-22T15:53:35+00:00https://timmermanreport.com/wp-content/uploads/2026/01/renaud.pnghttps://timmermanreport.com/2026/01/helping-people-lose-weight-and-live-healthy-ron-renaud-on-the-long-run/as\_logotype\_positive-2/2026-01-22T15:54:41+00:00https://timmermanreport.com/wp-content/uploads/2026/01/AS\_Logotype\_Positive-1.pnghttps://timmermanreport.com/the-long-run/dash\_logo\_lock\_up\_rgb\_black-2/2026-01-22T16:16:10+00:00https://timmermanreport.com/wp-content/uploads/2026/01/dash\_logo\_lock\_up\_rgb\_black.jpghttps://timmermanreport.com/2026/01/gsk-scoops-up-rapt-genentech-bets-on-nc-relief-for-american-science/sharpless/2026-01-23T00:14:49+00:00https://timmermanreport.com/wp-content/uploads/2026/01/sharpless.pnghttps://timmermanreport.com/2026/01/gsk-scoops-up-rapt-genentech-bets-on-nc-relief-for-american-science/boothrapt/2026-01-23T00:15:15+00:00https://timmermanreport.com/wp-content/uploads/2026/01/boothrapt.pnghttps://timmermanreport.com/2016/03/draft-joe-biden-and-roy-vagelos-for-a-fair-deal-on-drug-pricing/pattymurray/2026-01-23T00:15:46+00:00https://timmermanreport.com/wp-content/uploads/2016/03/pattymurray-e1457219138698.jpghttps://timmermanreport.com/2026/01/science-and-industry-need-to-push-back-hard/cdelawalla/2026-01-25T21:29:01+00:00https://timmermanreport.com/wp-content/uploads/2026/01/cdelawalla.jpghttps://timmermanreport.com/2020/04/thinking-ahead-building-a-broad-arsenal-against-infectious-disease/ankit-mahadevia/2026-01-26T20:10:50+00:00https://timmermanreport.com/wp-content/uploads/2020/04/ankit-mahadevia.jpghttps://timmermanreport.com/2026/01/eikon-ipo-on-deck-biomarin-borrows-big-halozyme-rolls-with-the-surf/perlmutter/2026-01-30T00:14:11+00:00https://timmermanreport.com/wp-content/uploads/2026/01/perlmutter.pnghttps://timmermanreport.com/2023/05/preserving-the-biotech-social-contract-we-should-all-be-pitching-in/potts/2026-01-30T00:14:38+00:00https://timmermanreport.com/wp-content/uploads/2023/04/potts.jpghttps://timmermanreport.com/2026/01/eikon-ipo-on-deck-biomarin-borrows-big-halozyme-rolls-with-the-surf/gerlinghaus/2026-01-30T00:16:06+00:00https://timmermanreport.com/wp-content/uploads/2026/01/gerlinghaus.pnghttps://timmermanreport.com/2026/01/eikon-ipo-on-deck-biomarin-borrows-big-halozyme-rolls-with-the-surf/helen/2026-01-30T00:17:30+00:00https://timmermanreport.com/wp-content/uploads/2026/01/helen.pnghttps://timmermanreport.com/2026/01/eikon-ipo-on-deck-biomarin-borrows-big-halozyme-rolls-with-the-surf/lgarraway/2026-01-30T00:21:06+00:00https://timmermanreport.com/wp-content/uploads/2026/01/lgarraway.pnghttps://timmermanreport.com/2026/01/eikon-ipo-on-deck-biomarin-borrows-big-halozyme-rolls-with-the-surf/jebkeiper/2026-01-30T00:22:40+00:00https://timmermanreport.com/wp-content/uploads/2026/01/jebkeiper.pnghttps://timmermanreport.com/2026/01/eikon-ipo-on-deck-biomarin-borrows-big-halozyme-rolls-with-the-surf/fabian-2/2026-01-30T00:25:25+00:00https://timmermanreport.com/wp-content/uploads/2026/01/fabian.pnghttps://timmermanreport.com/2026/01/eikon-ipo-on-deck-biomarin-borrows-big-halozyme-rolls-with-the-surf/ramani/2026-01-30T00:41:44+00:00https://timmermanreport.com/wp-content/uploads/2026/01/ramani.jpghttps://timmermanreport.com/2019/01/hurricane-lantus-the-storm-that-will-finally-force-pharma-to-take-cost-effectiveness-and-budgetary-impact-seriously/alexharding/2026-02-04T22:31:57+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexharding.jpghttps://timmermanreport.com/2026/02/eikon-goes-public-generate-biomedicines-teed-up-sante-reloads/nally/2026-02-06T01:06:35+00:00https://timmermanreport.com/wp-content/uploads/2026/02/nally.jpghttps://timmermanreport.com/2026/02/eikon-goes-public-generate-biomedicines-teed-up-sante-reloads/omar/2026-02-06T01:07:22+00:00https://timmermanreport.com/wp-content/uploads/2026/02/omar.jpghttps://timmermanreport.com/2026/02/join-the-timmerman-traverse-for-damon-runyon-cancer-research/bishoppass/2026-02-07T03:27:59+00:00https://timmermanreport.com/wp-content/uploads/2026/02/bishoppass.pnghttps://timmermanreport.com/2026/02/join-the-timmerman-traverse-for-damon-runyon-cancer-research/piutepass/2026-02-07T03:29:05+00:00https://timmermanreport.com/wp-content/uploads/2026/02/piutepass.pnghttps://timmermanreport.com/2026/02/gear-check-timmerman-traverse-for-damon-runyon-heads-to-kilimanjaro/img\_9053/2026-02-09T14:05:29+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_9053-scaled.jpeghttps://timmermanreport.com/2026/02/gear-check-timmerman-traverse-for-damon-runyon-heads-to-kilimanjaro/img\_9070/2026-02-09T14:05:38+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_9070-scaled.jpeghttps://timmermanreport.com/2026/02/gear-check-timmerman-traverse-for-damon-runyon-heads-to-kilimanjaro/img\_9074-1/2026-02-09T14:09:07+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_9074.1.jpghttps://timmermanreport.com/2026/02/gear-check-timmerman-traverse-for-damon-runyon-heads-to-kilimanjaro/img\_9077-1/2026-02-09T14:09:10+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_9077.1.jpghttps://timmermanreport.com/2026/02/gear-check-timmerman-traverse-for-damon-runyon-heads-to-kilimanjaro/img\_9081-1/2026-02-09T14:10:13+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_9081.1.jpghttps://timmermanreport.com/2026/02/discovering-drugs-for-cancer-and-autoimmunity-ansu-satpathy/2026-healthcare-outlook-email/2026-02-09T14:59:47+00:00https://timmermanreport.com/wp-content/uploads/2026/02/2026-Healthcare-Outlook-Email.jpghttps://timmermanreport.com/2026/02/discovering-drugs-for-cancer-and-autoimmunity-ansu-satpathy/ansu/2026-02-10T03:30:29+00:00https://timmermanreport.com/wp-content/uploads/2026/02/ansu.jpghttps://timmermanreport.com/2026/02/discovering-drugs-for-cancer-and-autoimmunity-ansu-satpathy/as\_logotype\_positive-3/2026-02-17T07:29:10+00:00https://timmermanreport.com/wp-content/uploads/2026/02/AS\_Logotype\_Positive.pnghttps://timmermanreport.com/in-the-news/pulse/2026-02-19T18:11:29+00:00https://timmermanreport.com/wp-content/uploads/2026/02/pulse.pnghttps://timmermanreport.com/readers-saying/oleg-new-2026/2026-02-19T18:15:34+00:00https://timmermanreport.com/wp-content/uploads/2026/02/oleg-new-2026.pnghttps://timmermanreport.com/2026/02/fda-flip-flops-on-flu-vaccine-compass-passes-phase-3-jj-bets-on-pennsylvania/jviolin/2026-02-19T23:41:35+00:00https://timmermanreport.com/wp-content/uploads/2026/02/jviolin.pnghttps://timmermanreport.com/2019/08/autoimmunity-research-paves-the-way-for-new-ideas-in-halting-preventing-type-1-diabetes/jeff-bluestone\_2x2\_2017\_web/2026-02-19T23:43:01+00:00https://timmermanreport.com/wp-content/uploads/2019/08/Jeff-Bluestone\_2x2\_2017\_web.pnghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/image2/2026-02-20T14:05:11+00:00https://timmermanreport.com/wp-content/uploads/2026/02/image2-scaled.jpeghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/image4/2026-02-20T14:05:15+00:00https://timmermanreport.com/wp-content/uploads/2026/02/image4-rotated.jpeghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/barathi/2026-02-20T14:24:03+00:00https://timmermanreport.com/wp-content/uploads/2026/02/barathi.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/barranco/2026-02-20T14:24:04+00:00https://timmermanreport.com/wp-content/uploads/2026/02/barranco.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/bird/2026-02-20T14:24:05+00:00https://timmermanreport.com/wp-content/uploads/2026/02/bird.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/barranco1/2026-02-20T14:24:38+00:00https://timmermanreport.com/wp-content/uploads/2026/02/barranco1.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/cassidy/2026-02-20T14:24:39+00:00https://timmermanreport.com/wp-content/uploads/2026/02/cassidy.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/catherine/2026-02-20T14:25:13+00:00https://timmermanreport.com/wp-content/uploads/2026/02/catherine.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/flower/2026-02-20T14:25:15+00:00https://timmermanreport.com/wp-content/uploads/2026/02/flower.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/machame/2026-02-20T14:25:36+00:00https://timmermanreport.com/wp-content/uploads/2026/02/machame.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/relaxing/2026-02-20T14:25:38+00:00https://timmermanreport.com/wp-content/uploads/2026/02/relaxing.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/spence/2026-02-20T14:25:39+00:00https://timmermanreport.com/wp-content/uploads/2026/02/spence.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/sunesio/2026-02-20T14:26:03+00:00https://timmermanreport.com/wp-content/uploads/2026/02/sunesio.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/sunrise/2026-02-20T14:26:04+00:00https://timmermanreport.com/wp-content/uploads/2026/02/sunrise.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/warm/2026-02-20T14:26:05+00:00https://timmermanreport.com/wp-content/uploads/2026/02/warm.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/summit2026/2026-02-20T14:26:42+00:00https://timmermanreport.com/wp-content/uploads/2026/02/Summit2026.jpeghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/ateam/2026-02-20T14:27:04+00:00https://timmermanreport.com/wp-content/uploads/2026/02/ateam.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/andrea-2/2026-02-20T14:38:09+00:00https://timmermanreport.com/wp-content/uploads/2026/02/andrea.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/bird-2/2026-02-20T14:46:30+00:00https://timmermanreport.com/wp-content/uploads/2026/02/bird-1.jpghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/image5/2026-02-20T14:46:55+00:00https://timmermanreport.com/wp-content/uploads/2026/02/image5.jpeghttps://timmermanreport.com/2026/02/enjoy-the-photos-timmerman-traverse-for-damon-runyon-kilimanjaro-2026/heather/2026-02-20T14:47:49+00:00https://timmermanreport.com/wp-content/uploads/2026/02/heather.jpghttps://timmermanreport.com/2026/02/gilead-acquires-arcellx-alkermes-passes-the-torch-beam-borrows-big/doday/2026-02-27T03:13:13+00:00https://timmermanreport.com/wp-content/uploads/2026/02/doday.pnghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2453/2026-02-27T11:30:02+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2453-scaled.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2458-1/2026-02-27T11:33:50+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2458-1-rotated.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2455-1/2026-02-27T11:33:56+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2455-1.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2452-1/2026-02-27T11:34:00+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2452-1-rotated.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2449-1/2026-02-27T11:34:03+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2449-1-rotated.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2449-1-2/2026-02-27T11:40:45+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2449-1-1-rotated.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2455-1-2/2026-02-27T11:43:04+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2455-1-1.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2458-1-2/2026-02-27T11:47:28+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2458-1-1-rotated.jpeghttps://timmermanreport.com/2026/02/agency-the-motivational-currency-of-health/img\_2452-1-2/2026-02-27T11:49:25+00:00https://timmermanreport.com/wp-content/uploads/2026/02/IMG\_2452-1-1-rotated.jpeghttps://timmermanreport.com/2026/02/join-the-timmerman-traverse-for-damon-runyon-cancer-research/bishoppass-2/2026-02-28T20:08:14+00:00https://timmermanreport.com/wp-content/uploads/2026/02/bishoppass-1.pnghttps://timmermanreport.com/2026/02/join-the-timmerman-traverse-for-damon-runyon-cancer-research/piutepass-2/2026-02-28T20:08:41+00:00https://timmermanreport.com/wp-content/uploads/2026/02/piutepass-1.pnghttps://timmermanreport.com/2026/02/join-the-timmerman-traverse-for-damon-runyon-cancer-research/bobmore-4/2026-02-28T20:30:42+00:00https://timmermanreport.com/wp-content/uploads/2022/10/bobmore.pnghttps://timmermanreport.com/2020/06/making-a-difference-on-race-ted-love-on-the-long-run/tedlove2020/2026-02-28T20:33:48+00:00https://timmermanreport.com/wp-content/uploads/2020/06/tedlove2020.jpghttps://timmermanreport.com/2026/03/biotechs-deep-pool-of-midsized-companies/midcap1/2026-03-04T19:15:39+00:00https://timmermanreport.com/wp-content/uploads/2026/03/midcap1.pnghttps://timmermanreport.com/2026/03/biotechs-deep-pool-of-midsized-companies/midcap2/2026-03-04T19:17:30+00:00https://timmermanreport.com/wp-content/uploads/2026/03/midcap2.pnghttps://timmermanreport.com/2026/03/biotechs-deep-pool-of-midsized-companies/midcap3/2026-03-04T19:17:31+00:00https://timmermanreport.com/wp-content/uploads/2026/03/midcap3.pnghttps://timmermanreport.com/2026/03/biotechs-deep-pool-of-midsized-companies/midcap4/2026-03-04T19:17:33+00:00https://timmermanreport.com/wp-content/uploads/2026/03/midcap4.pnghttps://timmermanreport.com/2026/03/biotechs-deep-pool-of-midsized-companies/midcap1-1/2026-03-04T19:19:48+00:00https://timmermanreport.com/wp-content/uploads/2026/03/midcap1.1.pnghttps://timmermanreport.com/2026/03/candid-goes-public-uniqures-fda-dispute-modernas-big-legal-bill/kapusta/2026-03-06T02:08:46+00:00https://timmermanreport.com/wp-content/uploads/2026/03/kapusta.pnghttps://timmermanreport.com/2026/03/candid-goes-public-uniqures-fda-dispute-modernas-big-legal-bill/gibson-4/2026-03-06T02:11:18+00:00https://timmermanreport.com/wp-content/uploads/2026/03/gibson.pnghttps://timmermanreport.com/2025/12/biotechs-future-will-be-more-distributed/jflavin/2026-03-06T02:12:00+00:00https://timmermanreport.com/wp-content/uploads/2025/12/jflavin.jpghttps://timmermanreport.com/about-luke-timmerman/54425179810\_ce35cba44e\_k/2026-03-07T00:16:06+00:00https://timmermanreport.com/wp-content/uploads/2026/03/54425179810\_ce35cba44e\_k.jpghttps://timmermanreport.com/about-luke-timmerman/tr10alnylam/2026-03-07T00:16:52+00:00https://timmermanreport.com/wp-content/uploads/2026/03/TR10alnylam-scaled.jpeghttps://timmermanreport.com/2026/03/eli-lillys-last-20-acquisitions-and-the-opportunity-for-more/lillyfreecash/2026-03-10T23:48:12+00:00https://timmermanreport.com/wp-content/uploads/2026/03/Lillyfreecash.pnghttps://timmermanreport.com/2024/04/vertex-antes-for-alpine-regeneron-faces-doj-illumina-shakeup-continues/gold/2026-03-12T22:31:56+00:00https://timmermanreport.com/wp-content/uploads/2024/04/gold.pnghttps://timmermanreport.com/2025/11/london-life-sciences-week-shows-uk-biotech-is-open-and-thriving/rosier/2026-03-12T22:32:46+00:00https://timmermanreport.com/wp-content/uploads/2025/11/rosier.jpghttps://timmermanreport.com/2026/03/servier-buys-day-one-vertex-hits-igan-phase-iii-prasads-unceremonious-exit-at-fda/aarondeves/2026-03-12T22:34:06+00:00https://timmermanreport.com/wp-content/uploads/2026/03/aarondeves.pnghttps://timmermanreport.com/2026/03/servier-buys-day-one-vertex-hits-igan-phase-iii-prasads-unceremonious-exit-at-fda/dipal/2026-03-12T22:36:15+00:00https://timmermanreport.com/wp-content/uploads/2026/03/dipal.pnghttps://timmermanreport.com/2026/03/servier-buys-day-one-vertex-hits-igan-phase-iii-prasads-unceremonious-exit-at-fda/beckyp/2026-03-12T22:37:22+00:00https://timmermanreport.com/wp-content/uploads/2026/03/beckyp.pnghttps://timmermanreport.com/2026/03/european-biotechs-investment-crisis-otello-stampacchia-on-the-long-run/2026-healthcare-outlook-email-2/2026-03-17T22:23:40+00:00https://timmermanreport.com/wp-content/uploads/2026/03/2026-Healthcare-Outlook-Email.jpghttps://timmermanreport.com/2026/03/european-biotechs-investment-crisis-otello-stampacchia-on-the-long-run/tracking-key-healthcare-and-biopharma-trends-email/2026-03-17T22:47:55+00:00https://timmermanreport.com/wp-content/uploads/2026/03/Tracking-Key-Healthcare-and-Biopharma-Trends-Email.jpghttps://timmermanreport.com/2026/03/mercks-davis-era-acquisitions-enough-for-life-after-keytruda/robdavis/2026-03-23T17:45:10+00:00https://timmermanreport.com/wp-content/uploads/2026/03/robdavis.pnghttps://timmermanreport.com/2026/03/merck-snaps-up-new-cancer-drug-denali-grows-up-gileads-tce-wager/amyb/2026-03-26T22:29:41+00:00https://timmermanreport.com/wp-content/uploads/2026/03/amyb.pnghttps://timmermanreport.com/2026/03/merck-snaps-up-new-cancer-drug-denali-grows-up-gileads-tce-wager/jaideep\_dudani\_101425/2026-03-26T22:30:43+00:00https://timmermanreport.com/wp-content/uploads/2026/03/jaideep\_dudani\_101425.jpghttps://timmermanreport.com/2026/03/merck-snaps-up-new-cancer-drug-denali-grows-up-gileads-tce-wager/pablo/2026-03-26T22:33:04+00:00https://timmermanreport.com/wp-content/uploads/2026/03/pablo.pnghttps://timmermanreport.com/2026/03/inspired-by-mother-nature-discovering-new-drugs-viswa-colluru-on-the-long-run/vcolluru/2026-03-31T17:41:04+00:00https://timmermanreport.com/wp-content/uploads/2026/03/vcolluru.jpghttps://timmermanreport.com/2025/06/ai-drug-discovery-a-revolution-for-the-underdogs/aaronring/2026-04-02T16:44:43+00:00https://timmermanreport.com/wp-content/uploads/2025/06/aaronring.pnghttps://timmermanreport.com/2026/04/stipple-bio-discovering-new-cancer-drug-targets-secures-100m/jefflandau/2026-04-02T16:46:15+00:00https://timmermanreport.com/wp-content/uploads/2026/04/jefflandau.jpghttps://timmermanreport.com/2026/04/lilly-buys-centessa-takeda-alumis-tyk2-showdown-blackstones-megafund/bio-cedric-francois-bw/2026-04-02T23:56:31+00:00https://timmermanreport.com/wp-content/uploads/2026/04/bio-cedric-francois-bw.jpghttps://timmermanreport.com/2026/04/the-unreasonable-effectiveness-of-lifestyle/screenshot-2026-04-04-at-8-33-55%e2%80%afpm/2026-04-05T00:34:39+00:00https://timmermanreport.com/wp-content/uploads/2026/04/Screenshot-2026-04-04-at-8.33.55%E2%80%AFPM.pnghttps://timmermanreport.com/2026/04/the-unreasonable-effectiveness-of-lifestyle/screenshot-2026-03-18-at-4-28-32%e2%80%afpm/2026-04-05T00:50:14+00:00https://timmermanreport.com/wp-content/uploads/2026/04/Screenshot-2026-03-18-at-4.28.32%E2%80%AFPM.pnghttps://timmermanreport.com/2026/04/the-unreasonable-effectiveness-of-lifestyle/screenshot-2026-03-18-at-4-29-12%e2%80%afpm/2026-04-05T00:51:15+00:00https://timmermanreport.com/wp-content/uploads/2026/04/Screenshot-2026-03-18-at-4.29.12%E2%80%AFPM.pnghttps://timmermanreport.com/2026/04/computation-culture-for-drug-discovery-abbas-kazimi-on-the-long-run/as-ai-drug-discovery-email-register/2026-04-07T12:49:15+00:00https://timmermanreport.com/wp-content/uploads/2026/04/AS-AI-Drug-Discovery-Email-Register.pnghttps://timmermanreport.com/2026/04/sidewinder-bio-advances-bispecific-adc-for-cancer-to-clinic-pockets-137m/em1/2026-04-07T22:06:47+00:00https://timmermanreport.com/wp-content/uploads/2026/04/em1.jpghttps://timmermanreport.com/2026/04/gileads-deal-streak-neurocrine-grows-stipple-sidewinder-megarounds/acarpenter/2026-04-09T22:27:44+00:00https://timmermanreport.com/wp-content/uploads/2026/04/acarpenter.pnghttps://timmermanreport.com/2026/04/big-monday-revmed-sprye-ideaya-allogene-in-the-news/gold-2/2026-04-13T15:44:38+00:00https://timmermanreport.com/wp-content/uploads/2026/04/gold.pnghttps://timmermanreport.com/2026/04/big-monday-revmed-sprye-ideaya-allogene-in-the-news/turtle/2026-04-13T15:46:06+00:00https://timmermanreport.com/wp-content/uploads/2026/04/turtle.pnghttps://timmermanreport.com/2026/04/big-monday-revmed-sprye-ideaya-allogene-in-the-news/hata/2026-04-13T15:47:46+00:00https://timmermanreport.com/wp-content/uploads/2026/04/hata.pnghttps://timmermanreport.com/2026/04/big-monday-revmed-sprye-ideaya-allogene-in-the-news/dchang-2/2026-04-13T15:48:58+00:00https://timmermanreport.com/wp-content/uploads/2026/04/dchang.pnghttps://timmermanreport.com/2026/04/phasev-sponsors-timmerman-traverse-for-damon-runyon-cancer-research/raviv/2026-04-14T00:09:35+00:00https://timmermanreport.com/wp-content/uploads/2026/04/raviv.jpghttps://timmermanreport.com/2026/04/phasev-sponsors-timmerman-traverse-for-damon-runyon-cancer-research/phasev-logo/2026-04-14T00:10:39+00:00https://timmermanreport.com/wp-content/uploads/2026/04/PhaseV\_logo-scaled.jpghttps://timmermanreport.com/2026/04/phasev-sponsors-timmerman-traverse-for-damon-runyon-cancer-research/trv/2026-04-14T00:12:24+00:00https://timmermanreport.com/wp-content/uploads/2026/04/trv.pnghttps://timmermanreport.com/2026/04/phasev-sponsors-timmerman-traverse-for-damon-runyon-cancer-research/bishoppass-3/2026-04-14T00:14:39+00:00https://timmermanreport.com/wp-content/uploads/2026/04/bishoppass.pnghttps://timmermanreport.com/2026/04/revmeds-groundbreaking-data-lilly-acquires-crossbridge-ipos-line-up/cbehrenbruch/2026-04-16T20:00:11+00:00https://timmermanreport.com/wp-content/uploads/2026/04/cbehrenbruch.pnghttps://timmermanreport.com/2026/04/revmeds-groundbreaking-data-lilly-acquires-crossbridge-ipos-line-up/sislam/2026-04-16T20:01:45+00:00https://timmermanreport.com/wp-content/uploads/2026/04/sislam.pnghttps://timmermanreport.com/2026/04/revmeds-groundbreaking-data-lilly-acquires-crossbridge-ipos-line-up/dzohar-2/2026-04-16T20:03:37+00:00https://timmermanreport.com/wp-content/uploads/2026/04/dzohar.pnghttps://timmermanreport.com/2026/04/revmeds-groundbreaking-data-lilly-acquires-crossbridge-ipos-line-up/cbaum\_6-26-2416833-bod-e1721923859563/2026-04-16T20:04:30+00:00https://timmermanreport.com/wp-content/uploads/2026/04/CBaum\_6.26.2416833-BOD-e1721923859563.jpghttps://timmermanreport.com/2026/04/revmeds-groundbreaking-data-lilly-acquires-crossbridge-ipos-line-up/torres\_michael\_4x/2026-04-16T20:05:31+00:00https://timmermanreport.com/wp-content/uploads/2026/04/Torres\_Michael\_4x.pnghttps://timmermanreport.com/2021/05/11-asian-american-executives-shaping-the-future-of-biopharma/vasn/2026-04-16T20:13:14+00:00https://timmermanreport.com/wp-content/uploads/2021/05/vasn.pnghttps://timmermanreport.com/2025/02/aligning-risk-benefit-assessments-in-sickle-cell-and-oncology-therapies/alan-2/2026-04-20T18:39:40+00:00https://timmermanreport.com/wp-content/uploads/2025/02/alan-e1739239415682.jpghttps://timmermanreport.com/2026/04/small-molecules-can-do-amazing-things-martin-burke-on-the-long-run/mburke/2026-04-21T13:25:31+00:00https://timmermanreport.com/wp-content/uploads/2026/04/mburke.pnghttps://timmermanreport.com/2026/04/small-molecules-can-do-amazing-things-martin-burke-on-the-long-run/alphaearnings/2026-04-21T13:26:57+00:00https://timmermanreport.com/wp-content/uploads/2026/04/alphaearnings.pnghttps://timmermanreport.com/2026/04/lilly-buys-in-vivo-car-t-psychedelics-in-the-fast-lane-nektar-surges-on-hair-loss-drug/carls/2026-04-23T22:44:38+00:00https://timmermanreport.com/wp-content/uploads/2026/04/carls.pnghttps://timmermanreport.com/2026/04/lilly-buys-in-vivo-car-t-psychedelics-in-the-fast-lane-nektar-surges-on-hair-loss-drug/friedman/2026-04-23T22:47:00+00:00https://timmermanreport.com/wp-content/uploads/2026/04/friedman.pnghttps://timmermanreport.com/2026/04/orukas-psoriasis-contender-intellia-passes-phase-iii-veradermics-roars/klein/2026-04-27T19:30:07+00:00https://timmermanreport.com/wp-content/uploads/2026/04/klein.pnghttps://timmermanreport.com/2026/04/orukas-psoriasis-contender-intellia-passes-phase-iii-veradermics-roars/chrispeetz/2026-04-27T19:31:40+00:00https://timmermanreport.com/wp-content/uploads/2026/04/chrispeetz.pnghttps://timmermanreport.com/2026/04/orukas-psoriasis-contender-intellia-passes-phase-iii-veradermics-roars/waldman/2026-04-27T19:32:59+00:00https://timmermanreport.com/wp-content/uploads/2026/04/waldman.pnghttps://timmermanreport.com/2026/04/biotech-ipo-scorecard-investors-rewarded-for-bets-on-new-medicines-in-2026/avalyn-team-lyn0126/2026-04-29T18:29:05+00:00https://timmermanreport.com/wp-content/uploads/2026/04/avalyn-team-Lyn0126.jpghttps://timmermanreport.com/2026/04/biotech-ipo-scorecard-investors-rewarded-for-bets-on-new-medicines-in-2026/avalyn-team-lyn0126-2/2026-04-29T18:29:32+00:00https://timmermanreport.com/wp-content/uploads/2026/04/avalyn-team-Lyn0126-1.jpghttps://timmermanreport.com/2026/04/an-ipo-trio-veradermics-hair-loss-win-erascas-rough-week/jlim/2026-04-30T23:22:03+00:00https://timmermanreport.com/wp-content/uploads/2026/04/jlim.pnghttps://timmermanreport.com/2026/05/ucb-takes-over-candid-arvinas-big-day-makarys-rough-week/rteel/2026-05-07T23:41:41+00:00https://timmermanreport.com/wp-content/uploads/2026/05/rteel.jpghttps://timmermanreport.com/2026/05/ucb-takes-over-candid-arvinas-big-day-makarys-rough-week/luca/2026-05-07T23:42:47+00:00https://timmermanreport.com/wp-content/uploads/2026/05/luca.jpghttps://timmermanreport.com/2026/05/ucb-takes-over-candid-arvinas-big-day-makarys-rough-week/glick/2026-05-07T23:44:39+00:00https://timmermanreport.com/wp-content/uploads/2026/05/glick.pnghttps://timmermanreport.com/2026/05/ucb-takes-over-candid-arvinas-big-day-makarys-rough-week/kiran-mazumdar-shaw-150x150/2026-05-07T23:46:50+00:00https://timmermanreport.com/wp-content/uploads/2026/05/Kiran-Mazumdar-Shaw-150x150-1.jpghttps://timmermanreport.com/2026/05/ucb-takes-over-candid-arvinas-big-day-makarys-rough-week/markary\_martin\_900x900-flag-adj/2026-05-07T23:50:19+00:00https://timmermanreport.com/wp-content/uploads/2026/05/markary\_martin\_900x900-flag-adj.jpghttps://timmermanreport.com/2026/05/ai-in-practice/screenshot-2026-05-09-at-11-13-09%e2%80%afam/2026-05-09T19:35:16+00:00https://timmermanreport.com/wp-content/uploads/2026/05/Screenshot-2026-05-09-at-11.13.09%E2%80%AFAM.pnghttps://timmermanreport.com/2026/05/fda-boss-pushed-out-bms-bets-on-china-isomorphics-megaround/rgnx/2026-05-15T00:43:32+00:00https://timmermanreport.com/wp-content/uploads/2026/05/rgnx.pnghttps://timmermanreport.com/2026/05/fda-boss-pushed-out-bms-bets-on-china-isomorphics-megaround/diamond-2/2026-05-15T00:47:59+00:00https://timmermanreport.com/wp-content/uploads/2026/05/diamond.pnghttps://timmermanreport.com/2026/05/fda-boss-pushed-out-bms-bets-on-china-isomorphics-megaround/davis/2026-05-15T00:54:00+00:00https://timmermanreport.com/wp-content/uploads/2026/05/davis.pnghttps://timmermanreport.com/2020/03/the-biopharmaceutical-counterattack/jeremy\_levin\_005/2026-05-19T13:37:07+00:00https://timmermanreport.com/wp-content/uploads/2020/03/jeremy\_levin\_005.jpghttps://timmermanreport.com/2026/05/lillys-triple-g-delivers-parabilis-eyes-ipo-regenerons-lag-3-whiff/sanjivpatel/2026-05-22T00:13:16+00:00https://timmermanreport.com/wp-content/uploads/2026/05/sanjivpatel.pnghttps://timmermanreport.com/2026/05/vaccines-get-a-boost-apogee-hunts-down-dupixent-gsk-raises-the-bar-in-hepb/gsimeon/2026-05-28T22:12:00+00:00https://timmermanreport.com/wp-content/uploads/2026/05/gsimeon.pnghttps://timmermanreport.com/2026/05/vaccines-get-a-boost-apogee-hunts-down-dupixent-gsk-raises-the-bar-in-hepb/mhenderson/2026-05-28T22:14:02+00:00https://timmermanreport.com/wp-content/uploads/2026/05/mhenderson.pnghttps://timmermanreport.com/timmerman-traverse-for-damon-runyon-2025/jodie-morrison/2026-05-28T22:16:41+00:00https://timmermanreport.com/wp-content/uploads/2024/10/jodie-morrison.jpghttps://timmermanreport.com/2026/06/reimagining-science-for-the-ai-era-becky-pferdehirt-on-the-long-run/as-ai-in-drug-development-2026-email/2026-06-02T19:24:27+00:00https://timmermanreport.com/wp-content/uploads/2026/06/AS-AI-in-Drug-Development-2026-Email.jpghttps://timmermanreport.com/2025/12/psithera-gets-47-5m-for-small-molecules-against-tnf-superfamily-targets/woody\_sherman\_headshot\_2024/2026-06-02T20:38:43+00:00https://timmermanreport.com/wp-content/uploads/2025/12/Woody\_Sherman\_headshot\_2024.jpghttps://timmermanreport.com/2026/06/revmeds-moment-in-the-sun-in-vivo-car-ts-shine-newlimits-healthspan-haul/oyler/2026-06-04T23:58:22+00:00https://timmermanreport.com/wp-content/uploads/2026/06/oyler.pnghttps://timmermanreport.com/2026/06/revmeds-moment-in-the-sun-in-vivo-car-ts-shine-newlimits-healthspan-haul/jie/2026-06-05T00:00:40+00:00https://timmermanreport.com/wp-content/uploads/2026/06/jie.jpghttps://timmermanreport.com/2019/10/biotechs-film-making-exec-behind-jim-allison-breakthrough/billhaney/2026-06-05T00:01:07+00:00https://timmermanreport.com/wp-content/uploads/2019/10/billhaney.jpghttps://timmermanreport.com/2026/06/revmeds-moment-in-the-sun-in-vivo-car-ts-shine-newlimits-healthspan-haul/jeff-legos/2026-06-05T00:03:09+00:00https://timmermanreport.com/wp-content/uploads/2026/06/Jeff-Legos.pnghttps://timmermanreport.com/2026/06/city-therapeutics-pockets-99-5m-advancing-multiple-rnai-candidates-to-the-clinic/andyorth/2026-06-08T21:54:03+00:00https://timmermanreport.com/wp-content/uploads/2026/06/andyorth.jpghttps://timmermanreport.com/2026/06/city-therapeutics-pockets-99-5m-advancing-multiple-rnai-candidates-to-the-clinic/rohan/2026-06-08T21:55:19+00:00https://timmermanreport.com/wp-content/uploads/2026/06/rohan.pnghttps://timmermanreport.com/2026/06/parabilis-ipo-pops-jj-buys-more-degraders-gsks-precision-oncology-bet/lukemiels/2026-06-11T23:39:44+00:00https://timmermanreport.com/wp-content/uploads/2026/06/lukemiels.pnghttps://timmermanreport.com/2026/06/parabilis-ipo-pops-jj-buys-more-degraders-gsks-precision-oncology-bet/joshbilenker/2026-06-11T23:41:24+00:00https://timmermanreport.com/wp-content/uploads/2026/06/joshbilenker.png